This video is an interview
with a physician and his two family members documenting and discussing
the response to initiation of perispinal etanercept at the INR.
For the published results please see Rapid cognitive improvement
in Alzheimer's disease following perispinal etanercept administration.
Edward Tobinick MD, Hyman Gross MD. Journal of Neuroinflammation
2008 January; 5:2.The videos above are interviews discussing
and documenting the clinical response to initiation of anti-TNF
treatment (perispinal etanercept) at the INR. For
the published results please see Tobinick E, Gross H, Weinberger
A, Cohen H., TNF-alpha Modulation for Treatment of Alzheimer's
Disease: A 6-Month Pilot Study MedGenMed 2006; 8(2) :25;
Tobinick E., Perispinal etanercept for treatment of Alzheimer's
disease, Current Alzheimer Research 2007 Dec; 4(5):550-2;
Tobinick E, Gross H., Rapid improvement in verbal fluency
and aphasia following perispinal etanercept in Alzheimer's disease,
BMC Neurology 2008; 8:27; and Tobinick E., Perispinal
etanercept for neuroinflammatory disorders, Drug Discovery
Today 2009 Feb; 14(3-4):168-77.Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Video2